Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw
Published on 08/07/2025 at 18:05 | prnewswire.co.uk
en | GG00B3FHW224 | MENARINIS | boerse | 67973441 |
